The fusion protein Arcalyst (rilonacept), an IL-1 trap that acts as a soluble decoy receptor, is also marketed by Regeneron Pharmaceuticals, of Tarrytown, New York. Ilaris is, however, the first ...
After hours: February 7 at 7:49:44 PM EST Loading Chart for REGN ...
After hours: 7 February at 19:49:44 GMT-5 ...
Pre-Market: 6:59:59 a.m. EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback